This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Angiotensin-Converting Enzyme 3D structures
From Proteopedia
(Difference between revisions)
| Line 10: | Line 10: | ||
**[[2c6f]] – hANCE N domain<br /> | **[[2c6f]] – hANCE N domain<br /> | ||
**[[2x8y]] – DmANCE – Drosophila melanogaster<br /> | **[[2x8y]] – DmANCE – Drosophila melanogaster<br /> | ||
| + | **[[6s1y]] – moANCE N domain - mosquito<br /> | ||
*Angiotensin Converting Enzyme N domain (1-641) complex | *Angiotensin Converting Enzyme N domain (1-641) complex | ||
**[[2c6n]], [[1o86]], [[4c2p]], [[2ydm]], [[1uze]], [[1uzf]], [[6h5x]] - hANCE + anti-hypertensive drug<br /> | **[[2c6n]], [[1o86]], [[4c2p]], [[2ydm]], [[1uze]], [[1uzf]], [[6h5x]] - hANCE + anti-hypertensive drug<br /> | ||
| - | **[[6en5]], [[6en6]], [[4bzr]] - hANCE + inhibitor<br /> | + | **[[6en5]], [[6en6]], [[4bzr]], [[6tt4]] - hANCE + inhibitor<br /> |
| - | **[[4bzs]] – hANCE (mutant) + inhibitor<br /> | + | **[[4bzs]], [[6tt3]] – hANCE (mutant) + inhibitor<br /> |
**[[6f9r]], [[6f9t]], [[6f9u]], [[6f9v]] - hANCE + chronic heart failure drug<br /> | **[[6f9r]], [[6f9t]], [[6f9u]], [[6f9v]] - hANCE + chronic heart failure drug<br /> | ||
| - | **[[3kbh]], [[3d0g]], [[3d0h]], [[3d0i]], [[2ajf]], [[3sci]], [[3scj]], [[3sck]], [[3scl]], [[6cs2]], [[6acg]], [[6acj]], [[6ack]] – hANCE 2 +spike glycoprotein<br /> | + | **[[3kbh]], [[3d0g]], [[3d0h]], [[3d0i]], [[2ajf]], [[3sci]], [[3scj]], [[3sck]], [[3scl]], [[6cs2]], [[6acg]], [[6acj]], [[6ack]], [[6lzg]], [[6m0j]], [[6vw1]] – hANCE 2 + spike glycoprotein<br /> |
| - | + | ||
**[[4bxk]], [[4ca5]], [[4ca7]], [[4ca8]], [[2xy9]], [[2xyd]] – hANCE + phosphinic inhibitor<br /> | **[[4bxk]], [[4ca5]], [[4ca7]], [[4ca8]], [[2xy9]], [[2xyd]] – hANCE + phosphinic inhibitor<br /> | ||
| - | **[[4ca6]] - hANCE N domain (mutant) + phosphinic inhibitor<br /> | + | **[[4ca6]], [[6tt1]] - hANCE N domain (mutant) + phosphinic inhibitor<br /> |
**[[4aph]] – hANCE + angiotensin II<br /> | **[[4aph]] – hANCE + angiotensin II<br /> | ||
| - | **[[4apj]] – hANCE + bradykinin-potentiating peptide B<br /> | + | **[[4apj]], [[6qs1]] – hANCE + bradykinin-potentiating peptide B<br /> |
**[[1r42]], [[1r4l]] – hANCE + disordered segment of collectrin homology domain<br /> | **[[1r42]], [[1r4l]] – hANCE + disordered segment of collectrin homology domain<br /> | ||
**[[2xhm]] – DmANCE+K inhibitor<br /> | **[[2xhm]] – DmANCE+K inhibitor<br /> | ||
| Line 29: | Line 29: | ||
**[[4aa2]], [[4asr]] – DmANCE + bradykinin-potentiating peptide B<br /> | **[[4aa2]], [[4asr]] – DmANCE + bradykinin-potentiating peptide B<br /> | ||
**[[4asq]] – DmANCE + bradykinin peptide<br /> | **[[4asq]] – DmANCE + bradykinin peptide<br /> | ||
| + | **[[6s1z]] – moANCE + fosinoprilat<br /> | ||
*Angiotensin Converting Enzyme C domain (642-1232) complex | *Angiotensin Converting Enzyme C domain (642-1232) complex | ||
| Line 36: | Line 37: | ||
**[[2oc2]], [[4ca5]], [[4ca7]], [[4ca8]] - hANCE+phosphinic inhibitor<br /> | **[[2oc2]], [[4ca5]], [[4ca7]], [[4ca8]] - hANCE+phosphinic inhibitor<br /> | ||
**[[6h5w]] - hANCE (mutant) + anti-hypertensive drug<br /> | **[[6h5w]] - hANCE (mutant) + anti-hypertensive drug<br /> | ||
| + | |||
| + | *Angiotensin Converting Enzyme complex | ||
| + | |||
| + | **[[6m1d]] – hANCE 2 + Na-dependent neutral amino acid transporter – Cryo EM<br /> | ||
| + | **[[6m17]], [[6m18]] – hANCE 2 + Na-dependent neutral amino acid transporter + spike glycoprotein – Cryo EM<br /> | ||
| + | |||
}} | }} | ||
[[Category: Topic Page]] | [[Category: Topic Page]] | ||
Revision as of 10:29, 4 June 2020
3D Structures of Angiotensin-Converting Enzyme
Updated on 04-June-2020
